Verition Fund Management
DXCM icon

Verition Fund Management’s DexCom DXCM Stock Holding History

Verition Fund Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$565K Sell
9,000
-21,700
-71% -$1.51M ﹤0.01% 1545
2025
Q4 		$2.04M Sell
30,700
-88,700
-74% -$5.73M 0.01% 1604
2025
Q3 		$8.03M Buy
119,400
+39,700
+50% +$3.14M 0.03% 684
2025
Q2 		$6.96M Buy
79,700
+21,100
+36% +$1.65M 0.03% 790
2025
Q1 		$4M Buy
58,600
+27,200
+87% +$2.22M 0.02% 1015
2024
Q4 		$2.44M Hold
31,400
– – 0.01% 1423
2024
Q3 		$2.11M Hold
31,400
– – 0.01% 1383
2024
Q2 		$3.56M Buy
31,400
+25,700
+451% +$3.25M 0.02% 923
2024
Q1 		$791K Buy
+5,700
New +$716K 0.01% 1749
2023
Q2 		– Sell
-21,100
Closed -$2.45M – 2280
2023
Q1 		$2.45M Buy
21,100
+9,900
+88% +$1.11M 0.03% 633
2022
Q4 		$1.27M Buy
+11,200
New +$1.23M 0.02% 815
2022
Q2 		– Sell
-34,000
Closed -$4.35M – 2531
2022
Q1 		$4.35M Buy
34,000
+18,000
+113% +$1.97M 0.05% 457
2021
Q4 		$2.15M Hold
16,000
– – 0.02% 839
2021
Q3 		$2.19M Buy
+16,000
New +$2.02M 0.02% 586

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Verition Fund Management's DXCM Position: Q1 2026 in Review

Verition Fund Management increased its DexCom (DXCM) stake by 32% in Q1 2026, buying an estimated $1.27M and bringing the position to 75,460 shares worth $4.74M. The position accounts for 0.03% of the portfolio, ranked #607.

Verition Fund Management first reported a position in DXCM in Q3 2014 and has held it in 31 quarters since. The position peaked at $9.02M in Q3 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Verition Fund Management held 75,460 shares of DexCom worth $4.74M as of Q1 2026.
  • Verition Fund Management bought 18,188 DexCom shares in Q1 2026, an estimated $1.27M.
  • DexCom made up 0.03% of Verition Fund Management's portfolio in Q1 2026, its #607 holding.
  • Verition Fund Management first reported a position in DexCom in Q3 2014 and has held it in 31 quarters since.
  • Verition Fund Management's DexCom position peaked at $9.02M in Q3 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.